In the context of moderate sedation for adult patients in dental anesthesia, mortality risks are influenced by various clinical and patient-specific factors. Identifying these risks is crucial to enhance procedural safety and patient outcomes.
One of the most significant causes of adult patient mortality during moderate sedation in dentistry is respiratory complications, particularly hypoxemia and airway obstruction. Implementing capnography as part of standard monitoring during moderate sedation can significantly enhance the early detection of adverse respiratory events and hypoxemia, thereby reducing the likelihood of severe outcomes such as brain damage, cardiac arrest, or death (Parker et al., 2018). This is supported by findings from a systematic review that underscores the necessity of vigilant monitoring to prevent respiratory depression associated with sedatives like midazolam (Conway et al., 2021). Failure to have monitoring on every sedation patient, including EtCO2, SpO2, ECG, NIBP, and Temperature can, and do, lead to catastrophic outcomes in patients who were previously in good physical condition prior to procedure; this coupled with the inability to manage airway and ventilation to the current science standards, leads to high mortality events.
The incidence of bradycardia during moderate sedation in dental anesthesia is a significant concern, especially with agents such as dexmedetomidine, midazolam, or combinations of sedatives or the use of polypharmacy. Research indicates that various factors influence bradycardia rates and the relative safety of different sedative techniques. As an example, Dexmedetomidine (Precedex), an α2-receptor agonist, is commonly used for sedation due to its efficacy and minimal respiratory depression. However, it can lead to cardiovascular side effects, including bradycardia. Studies have shown a significant correlation between dexmedetomidine loading doses and the incidence of bradycardia; for instance, a loading dose of 0.7 µg/kg has been associated with a 25.3% incidence of bradycardia in certain populations (Ahn & Kim, 2022; (Kim & Ahn, 2022; . Additionally, higher loading doses (above 0.5 µg/kg) have been linked to an increased risk of hemodynamic instability, including bradycardia (Kim & Ahn, 2022; (Gong et al., 2016). Bradycardia is also frequently seem as an event secondary to hypoxia, as well as, acute coronary syndrome (ACS).
Alternative sedation methods can also lead to bradycardia, although the rates may be lower compared to dexmedetomidine. Comparative analyses have indicated that agents like ketamine and propofol tend to have a lower incidence of bradycardia compared to dexmedetomidine, emphasizing their favorable safety profiles during dental and surgical procedures (Swart et al., 2023; He et al., 2024). Selecting sedation systems that exhibit reduced bradycardia risks is particularly valuable in moderate sedation scenarios, where patient stability is essential.
Another contributing factor to increased mortality rates during moderate sedation is the variability in methods used across different practices. Some dental practitioners may not adhere strictly to protocols regarding patient assessment and the administration of sedation, potentially leading to adverse outcomes (Marinho et al., 2022). Moreover, while dental treatment performed under general anesthesia may show high mortality rates compared to other medical procedures, maintaining clear indications for when to utilize each sedation method is vital for minimizing risks (Vitale et al., 2023). This suggests that a thorough understanding of patient medical histories and risk stratification is essential for safe sedation practices (Lee et al., 2013).
Patient factors, including underlying health conditions and the American Society of Anesthesiologists (ASA) classification system, also play a critical role in the incidence of adverse events. The ASA classification provides a framework to assess individual risk levels, enabling healthcare providers to adjust sedation techniques accordingly (Marella et al., 2021). Furthermore, an increased prevalence of dental anxiety can lead to complications if patients are not adequately sedated, as evidenced by studies showing anxiety levels correlating with pain perception and subsequently impacting treatment success (Sh et al., 2022; Esmaeili et al., 2020).
Finally, understanding the procedural context is essential. The type of dental procedure being performed can influence the risks associated with sedation. Complex procedures might necessitate deeper levels of sedation, which, if not properly managed, can lead to higher mortality rates. Research indicates that adult patients undergoing more invasive dental procedures face heightened risks of complications, emphasizing the need for careful patient selection and adequate monitoring techniques before and during sedation (Marinho et al., 2022).
In summary, the primary causes of mortality related to moderate sedation in adult dental patients largely stem from respiratory complications, bradycardia, inadequate monitoring practices, variations in sedation methods, and patient-specific factors including anxiety levels and overall health. The implementation of comprehensive monitoring protocols and a robust understanding of sedation guidelines are crucial for mitigating these risks and ensuring patient safety during dental procedures.
References:
- Ahn, E. and Kim, H. (2022). Risk factors for dexmedetomidine-associated bradycardia during spinal anesthesia: retrospective study..
https://doi.org/10.21203/rs.3.rs-1780506/v1
- Gong, M., Man, Y., & Fu, Q. (2016). Incidence of bradycardia in pediatric patients receiving dexmedetomidine anesthesia: a meta-analysis. International Journal of Clinical Pharmacy, 39(1), 139-147.
https://doi.org/10.1007/s11096-016-0411-5
- Conway, A., Chang, K., Mafeld, S., & Sutherland, J. (2021). Midazolam for sedation before procedures in adults and children: a systematic review update. Systematic Reviews, 10(1).
https://doi.org/10.1186/s13643-021-01617-5
- Esmaeili, H., Malekzadeh, M., Esmaeili, D., & Nikeghbal, F. (2020). Dental anxiety and the effectiveness of local anesthesia. Brazilian Journal of Oral Sciences, 19, e208127.
https://doi.org/10.20396/bjos.v19i0.8658127
- He, T., Zhong, R., Zhong, W., Huang, G., & Liu, X. (2024). Effect of remimazolam on intra-operative hypotension. European Journal of Anaesthesiology, 41(12), 898-909.
https://doi.org/10.1097/eja.0000000000002057
- Kim, H. and Ahn, E. (2022). Risk factors for dexmedetomidine-associated bradycardia during spinal anesthesia: a retrospective study. Medicine, 101(43), e31306.
https://doi.org/10.1097/md.0000000000031306 ;
- Lee, H., Milgrom, P., Starks, H., & Burke, W. (2013). Trends in death associated with pediatric dental sedation and general anesthesia. Pediatric Anesthesia, 23(8), 741-746.
https://doi.org/10.1111/pan.12210
- Lei, H., Li, C., Miao, T., Jun, L., Liu, L., Ying, P., … & Xin, T. (2019). Incidence and risk factors of bradycardia in pediatric patients undergoing intranasal dexmedetomidine sedation. Acta Anaesthesiologica Scandinavica, 64(4), 464-471.
https://doi.org/10.1111/aas.13509
- Razavi, S. and Malekianzadeh, B. (2022). The efficacy and complications of deep sedation in pediatric dental patients: a retrospective cohort study. Anesthesiology Research and Practice, 2022, 1-4.
https://doi.org/10.1155/2022/5259283 ;
- Marella, H., Saleem, N., & Tombazzi, C. (2021). Impact of moderate versus deep sedation and trainee participation on adenoma detection rate-analysis of a veteran population. Clinical Endoscopy, 54(2), 250-255.
https://doi.org/10.5946/ce.2020.091
- Marinho, M., Ramos, F., Cardoso, A., Silva-Júnior, G., Faria, M., Bastos, L., … & Picciani, B. (2022). Dental treatment under general anesthesia in patients with special needs provided by private and public healthcare services—a retrospective, comparative study. Healthcare, 10(6), 1147.
https://doi.org/10.3390/healthcare10061147
- Parker, W., Estrich, C., Abt, E., Carrasco–Labra, A., Waugh, J., Conway, A., … & Araujo, M. (2018). Benefits and harms of capnography during procedures involving moderate sedation. The Journal of the American Dental Association, 149(1), 38-50.e2.
https://doi.org/10.1016/j.adaj.2017.08.030
- Sh, M., Kaviani, N., Salimian, K., & Tajmiri, G. (2022). Effect of dexmedetomidine added to lidocaine cartridge on the level of patient sedation, cooperation, and patient and surgeon satisfaction during mandibular third‐molar extraction surgery: a randomized double‐blind controlled trial. International Journal of Dentistry, 2022(1).
https://doi.org/10.1155/2022/4722674
- Swart, R., Maes, S., Cavanaugh, D., & Mason, K. (2023). Remimazolam pilot for office-based dental sedation: adverse events, awareness and outcomes. Journal of Clinical Medicine, 12(23), 7308.
https://doi.org/10.3390/jcm12237308 ;
- Vitale, M., Gallo, S., Pascadopoli, M., Alcozer, R., Ciuffreda, C., & Scribante, A. (2023). Local anesthesia with sleeperone s4 computerized device vs traditional syringe and perceived pain in pediatric patients: a randomized clinical trial. Journal of Clinical Pediatric Dentistry.
https://doi.org/10.22514/jocpd.2023.002